(Q40185060)

18 September 2017

A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis (English)

1 reference

18 September 2017

0 references

1 reference

Thangarajh M

1

1 reference

18 September 2017

Masterman T

2

1 reference

18 September 2017

Hillert J

3

1 reference

18 September 2017

Moerk S

4

1 reference

18 September 2017

Jonsson R

5

1 reference

18 September 2017

1 January 2007

1 reference

Scandinavian Journal of Immunology

18 September 2017

1 reference

18 September 2017

65

1 reference

18 September 2017

1

1 reference

18 September 2017

92-98

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

18 September 2017

1 reference

Axonal pathology in multiple sclerosis: relationship to neurologic disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Multiple sclerosis--the plaque and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

An APRIL to remember: novel TNF ligands as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

BAFF AND APRIL: a tutorial on B cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Raised serum APRIL levels in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Increased levels of APRIL (a proliferation-inducing ligand) mRNA in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Impaired IgA class switching in APRIL-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

APRIL promotes B-1 cell-associated neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Identification of proteoglycans as the APRIL-specific binding partners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Determinants of Human B Cell Migration Across Brain Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.01867.X

10.1111/J.1365-3083.2006.01867.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference